WA Seattle의 방광암 임상 시험
방광암 관련 연구 21개가 Seattle 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- 외 1개
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
피험자 모집 중2상
- University of Washington - Fred Hutchinson Cancer Center ( Site 0100), Seattle
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
피험자 모집 중2상
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- University of Washington Medical Center - Montlake, Seattle
Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
피험자 모집 중1/2상
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
피험자 모집 중1/2상
- Eye Associates Northwest - Ballard Clinic and Surgery Center, Seattle
- Eye Associates Northwest - First Hill Clinic, Seattle
- Harborview Medical Center, Seattle
- 외 3개
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
피험자 모집 중1상
- Swedish Cancer Institute, Seattle
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
피험자 모집 중3상
- Fred Hutchinson Cancer Research Center ( Site 0787), Seattle
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
피험자 모집 중1/2상
- University of Washington Fred Hutchinson Cancer Center, Seattle
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
피험자 모집 중
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
피험자 모집 중1/2상
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
피험자 모집 중관찰 연구건강한 지원자 환영
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
피험자 모집 중관찰 연구
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
피험자 모집 중2/3상
- Local Institution - 0200, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
피험자 모집 중2상
- University of Washington School of Medicine, Seattle
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
피험자 모집 중3상
- Research Site, Seattle
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
피험자 모집 중2상
- Harborview Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
피험자 모집 중
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
피험자 모집 중1상
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
피험자 모집 중1상
- Fred Hutchinson Cancer Center, Seattle
Blue Light Cystoscopy With Cysview® Registry
피험자 모집 중관찰 연구
- University of Washington Medicine, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Seattle
다른 도시의 방광암 시험
- New York City, NY연구 35개
- Nashville, TN연구 31개
- Houston, TX연구 31개
- Dallas, TX연구 27개
- Boston, MA연구 26개
- Washington, DC연구 26개
- Los Angeles, CA연구 24개
- Baltimore, MD연구 24개
- St. Louis, MO연구 22개
- Philadelphia, PA연구 21개
- Edison, NJ연구 21개
- Chicago, IL연구 21개
Seattle의 다른 연구
- 비소세포폐암연구 53개
- 암 (전체)연구 49개
- 전립선암연구 42개
- 급성 골수성 백혈병연구 40개
- 유방암연구 39개
- 전이성 암연구 39개
- 대장직장암연구 34개
- 폐암연구 33개
- 난소암연구 30개
- 다발성 골수종연구 22개
- 골수형성이상증후군연구 21개
- 급성 림프모구성 백혈병연구 21개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.